MS associated with a 3.5-fold higher risk for mortality, 1.5-fold higher risk for cardiovascular mortality
Repetitive multiple cranial nerve blocks may offer a clinically meaningful benefit as a preventative measure in patients with chronic migraine.
Researchers evaluated sensory function in the trigeminocervical region in patients with cluster headache, migraine headache, and tension-type headache.
A narrative review summarizes recent data on the pathophysiology, epidemiology, and burden of disease and treatment of menstrual migraine.
Youth with a history of status migranosus are more likely to experience an increase of >4 headache days per month during a follow-up evaluation.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
Researchers sought to identify health care system factors that contribute to missed or delayed diagnosis of dementia by primary care providers.
Sleep-onset problems in the first year of life may precede an autism spectrum disorder diagnosis in children at higher risk for ASD.
Anti-calcitonin gene-related peptide monoclonal antibodies are the first approved pharmacologic treatments developed explicitly for the prevention of migraine.
Among patients with COVID-19 pneumonia in the intensive care unit with neurological symptoms, 44% of those undergoing magnetic resonance imaging have acute findings.
A diagnosis of amyotrophic lateral sclerosis can be overlooked by clinicians unfamiliar with the various signs of the disease.
Yoga plus medical care is better than medical therapy alone for the treatment of episodic migraines.
Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
More than one-third of medical staff members in hospitals during the COVID-19 outbreak in China reported insomnia symptoms.
While carefully timed light exposure may address sleep problems associated with circadian rhythm disturbances, studies that examine light therapies in the context of sleep disorders have been largely lacking in measures of adherence and acceptability of these approaches.
Idorsia announced positive topline results from a phase 3 study of daridorexant, an investigational dual orexin receptor antagonist, for the treatment of insomnia.
In this study, researchers sought to investigate the psychometric properties of the ASRS and WURS in a well-characterized sample of adult ADHD patients and population controls.
Depression and anxiety were significantly associated with sleep difficulties, including trouble falling asleep, early waking, coughing or snoring, feeling too cold or too hot, and having a bad dream.
Limited tools are available for identifying, diagnosing, and treating cognitive dysfunction from Alzheimer disease.
The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.